Arbutus Graham Net Net from 2010 to 2025
| ABUS Stock | USD 4.73 0.11 2.27% |
Graham Net Net | First Reported 2010-12-31 | Previous Quarter 0.48536877 | Current Value 0.46 | Quarterly Volatility 1.17045569 |
Check Arbutus Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arbutus Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 130.2 K or Selling General Administrative of 12.6 M, as well as many indicators such as Price To Sales Ratio of 103, Dividend Yield of 0.0529 or PTB Ratio of 7.98. Arbutus financial statements analysis is a perfect complement when working with Arbutus Biopharma Valuation or Volatility modules.
Arbutus | Graham Net Net | Build AI portfolio with Arbutus Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.